Search
EUROGIN 2010 roadmap on cervical cancer prevention
Peer-Reviewed Publication
Franceschi, S., Denny, L., Irwin, K.L., Jeronimo, J., Lopalco, P., L., Monsonego, J., Peto, J., Ronco, G., Sasieni, P., Wheeler, C.M.
News
Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based studyArchived
Similar to other European countries, cervical infection with HPV-16, the HPV type with the strongest oncogenic potential, were most common both overall and among women with cervical disease.
Publication
Information to guide individual health assessment of refugees fleeing the war in Ukraine - Considerations for healthcare workers
This document aims to provide information to guide individual health assessment carried out by frontline health providers to refugees fleeing Ukraine.
Publication
Hepatitis of unknown origin - Reporting protocol 2022
This reporting protocol is intended for reporting national case-based data for surveillance of hepatitis of unknown origin from all the countries and areas of the WHO European Region, including the 27 countries of the European Union (EU) and the additional three countries of the European Economic Area (EEA), to the European level.
Publication
Leaflet: Are you and your family protected from vaccine-preventable diseases?
Leaflet on vaccination for Ukrainian refugees.
Publication
Transitioning beyond the acute phase of the COVID-19 pandemic: Approaches and tools used by a sample of EU countries in the transition and de-escalation phase – interim report
In February and March 2022, ECDC carried out a series of dialogues with selected EU countries to discuss their approaches to transitioning into the post-acute phase of the pandemic and/or de-escalating measures, including their plans regarding specific key areas.
Publication
Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction
This document summarises evidence from studies included in the licensing file of HPV vaccines together with postlicensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV vaccines observed during the pre- and post-licensing period.
Data
Evidence of the efficacy of the 9vHPV vaccine
Efficacy/effectiveness, immunogenicity, safety and tolerability of the 9-valent HPV vaccine.
Publication
67th Advisory Forum meeting minutes, 14 December 2021
Minutes of the Sixty-seventh meeting of the ECDC Advisory Forum, 14 December 2021.
Publication
Antimicrobial Resistance in the EU/EEA - A One Health response
Joint report by ECDC, EFSA, EMA, and OECD on antimicrobial resistance in the EU/EEA and a One Health response. Antimicrobial resistance remains a serious challenge for everyone, a silent pandemic that calls for a One Health response in the EU/EEA.